SCHEMBL29323698

SCHEMBL29323698

CN(CCOCCO[Si](c1ccccc1)(c1ccccc1)C(C)(C)C)CC(O)CO

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
AURKA O14965 2/20 0.35
JAK2 O60674 2/20 0.35
ABL1 P00519 2/20 0.35
SRC P12931 1/20 0.35
CYP3A4 P08684 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
LMNA P02545 1/20 0.34
MAPK1 P28482 1/20 0.34
CDK1 P06493 1/20 0.34
CCNB1 P14635 1/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
ALDH1A1 P00352 2/20 0.34
ADRB2 P07550 1/20 0.32
ADRB1 P08588 1/20 0.32
SMYD2 Q9NRG4 1/20 0.32
KCNA5 P22460 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29322671 0.93 KDM4E (0.45) KDM4EL3MBTL1AURKAJAK2ABL1
SCHEMBL6571189 0.81 KDM4E (0.40) KDM4EL3MBTL1CYP3A4HTTSMN1; SMN2
SCHEMBL3409820 0.78 KCNH3 (0.38) CYP3A4HTTSMN1; SMN2MAPK1MEN1
SCHEMBL19451193 0.78 KCNH3 (0.38) CYP3A4HTTSMN1; SMN2MAPK1MEN1
SCHEMBL20423605 0.78 KCNH3 (0.38) CYP3A4HTTSMN1; SMN2MAPK1MEN1
SCHEMBL13311297 0.78 KCNH3 (0.38) CYP3A4HTTSMN1; SMN2MAPK1MEN1
SCHEMBL29025343 0.78 KCNH3 (0.38) CYP3A4HTTSMN1; SMN2MAPK1MEN1
SCHEMBL5150650 0.76 SMYD2 (0.39) KDM4ECYP3A4HTTSMN1; SMN2LMNA
SCHEMBL21810823 0.76 SMYD2 (0.39) KDM4ECYP3A4HTTSMN1; SMN2LMNA
SCHEMBL3833607 0.75 CYP3A4 (0.37) KDM4ECYP3A4HTTSMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4400491-A1 NOVEL LIPIDS USED FOR NUCLEIC ACID DELIVERY AND LIPID NANOPARTICLE COMPOSITION Themedium Therapeutics Co., Ltd (CN) 2024-07-17 EP disclosed